App-Quantinova.ai

Relevant complications with the retrograde approach: subanalysis of data from a 5-year Japanese multicentre CTO registry

Kashima Y - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Early nursing transfer after primary-PCI: the Salento model

Germinal F - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Primary percutaneous thrombectomy with coronary Right Judkins 8 Fr guide catheter for the treatment of high-risk acute pulmonary embolism

Berumen Dominguez L.E. - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Three-year midterm haemodynamic and durability outcomes of the European pivotal trial for second-generation balloon-expandable transcatheter heart valves

Walther T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Five-year outcome after transcatheter aortic valve implantation with CoreValve prosthesis

Barbanti M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Gastrointestinal bleeding in patients with atrial fibrillation and anticoagulant therapy: the role of percutaneous atrial appendage closure

Martin Yuste V - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Heparin

Safety and efficacy of left atrial appendage closure with the cardiac plug in high-risk patients with non-valvular atrial fibrillation and contraindications to oral anticoagulation

Kebernik J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Self-expanding transcatheter aortic valve: a pathology study

Sanchez O - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Feasibility of transcatheter closure of large atrial septal defect-secundum with absent superior or inferior rims

Al Hassani H - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Utilisation and clinical outcome assessment of trans-radial approach for coronary intervention - data from a large registry

Polad J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Crofelemer

Transradial catheterisation may decrease the radial artery luminal diameter and impair the vasodilatation response in the access site at late term: an observational study

Buturak A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitroglycerin

Safety and effectiveness of the Genous endothelial progenitor cell-capture stent in patients with Acute Coronary Syndrome and high-risk of post procedural bleeding

Obaid D - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention to octogenarians: a multi-centre cohort study

Watanabe M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Suloctidil

Impact of dual antiplatelet therapy on clinical outcomes 1 year after implantation of bioresorbable polymer drug eluting stent

Polad J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Crofelemer

Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent Induced Intimal Hyperplasia) PRODIGY trial

Costa F - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Comparative efficacy and safety of anticoagulation strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients

Schulze V - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Early experience implanting a polymer-free Biolimus A9 drug coated stent in patients treated with warfarin from two United Kingdom centres

Kinnaird T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Stent thrombosis in patients treated with bioresorbable vascular scaffolds: a meta-analysis of 7 studies and 2,568 patients

Quadri G - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Clinical follow-up after implantation of bioresorbable drug-eluting scaffolds- a prospective single-centre experience

Markovic S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

A clinical evaluation comparing the performance of bioresorbable vascular scaffold vs. permanent cobalt-chromium everolimus-eluting stent in patients with ST-elevation myocardial infarction undergoing primary PCI

Cortese B - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Filters

7277 Abstracts